Prosecution Insights
Last updated: April 19, 2026

Bioviva Usa Inc.

2 pending office actions

Portfolio Summary

2
Total Pending OAs
2
Final Rejections
0
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
17680708 GENE THERAPY USING GENETICALLY MODIFIED VIRAL VECTORS CONNORS, ALEXANDRA F 1634 Final Rejection Feb 25, 2022
17592803 SYSTEMS AND METHODS FOR GENE THERAPY VIA ADMINISTRATION OF GENETICALLY MODIFIED VIRAL VECTORS CONNORS, ALEXANDRA F 1634 Final Rejection Feb 04, 2022

Managing Bioviva Usa Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month